Groupama Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$105M Sell
874,963
-25,823
-3% -$2.98M 1.54% 20
2025
Q4
$94.8M Buy
900,786
+68,181
+8% +$6.4M 1.39% 18
2025
Q3
$69.9M Buy
832,605
+49,541
+6% +$4.08M 1.02% 24
2025
Q2
$61.9M Sell
783,064
-79,295
-9% -$6.3M 1.02% 24
2025
Q1
$76.9M Buy
862,359
+72,571
+9% +$6.78M 1.54% 16
2024
Q4
$77.7M Sell
789,788
-764,709
-49% -$78.8M 1.59% 14
2024
Q3
$69.6M Buy
1,554,497
+144,961
+10% +$17.2M 1.81% 10
2024
Q2
$87.6M Buy
1,409,536
+713,494
+103% +$91.9M 1.19% 19
2024
Q1
$98.8M Sell
696,042
-809,347
-54% -$99.8M 1.8% 12
2023
Q4
$83.1M Buy
+1,505,389
New +$156M 2.16% 9

Other funds holding MRK

Groupama Asset Management's MRK Position: Q1 2026 in Review

Groupama Asset Management reduced its Merck (MRK) stake by 2.9% in Q1 2026, selling an estimated $2.98M and leaving 874,963 shares worth $105M. The position accounts for 1.54% of the portfolio, ranked #20.

Groupama Asset Management first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Groupama Asset Management held 874,963 shares of Merck worth $105M as of Q1 2026.
  • Groupama Asset Management sold 25,823 Merck shares in Q1 2026, an estimated $2.98M.
  • Merck made up 1.54% of Groupama Asset Management's portfolio in Q1 2026, its #20 holding.
  • Groupama Asset Management first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Groupama Asset Management's 13F filing for Q1 2026, filed 22 May 2026.